Treace Medical Concepts, Inc. Debt Securities, Available-for-sale, Unrealized Gain
Treace Medical Concepts, Inc. (TMCI) reported Debt Securities, Available-for-sale, Unrealized Gain of $10.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedGain · last filed 2026-08-07
- Treace Medical Concepts, Inc. debt securities, available-for-sale, unrealized gain for the quarter ending 2026-06-30 was -$9.00K.
- Treace Medical Concepts, Inc. debt securities, available-for-sale, unrealized gain for the quarter ending 2026-03-31 was $19.00K, a 70.77% decline year-over-year.
- Treace Medical Concepts, Inc. debt securities, available-for-sale, unrealized gain for the quarter ending 2025-12-31 was -$10.00K.
- Treace Medical Concepts, Inc. debt securities, available-for-sale, unrealized gain for the quarter ending 2025-09-30 was $27.00K, a 82.35% decline year-over-year.
- Treace Medical Concepts, Inc. debt securities, available-for-sale, unrealized gain for fiscal 2024 was $100.00K, a 48.98% decline from fiscal 2023.
- Treace Medical Concepts, Inc. debt securities, available-for-sale, unrealized gain for fiscal 2023 was $196.00K, a 148.10% increase from fiscal 2022.
- Treace Medical Concepts, Inc. debt securities, available-for-sale, unrealized gain for fiscal 2022 was $79.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Gain 3 month | Debt Securities, Available-for-sale, Unrealized Gain 6 month | Debt Securities, Available-for-sale, Unrealized Gain 9 month | Debt Securities, Available-for-sale, Unrealized Gain 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $10.00K 10-Q · filed 2026-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-08-07 | $27.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $19.00K 10-Q · filed 2026-05-08 | $9.00K derived: sum of 2 quarters · filed 2026-08-07 | $36.00K derived: sum of 3 quarters · filed 2026-08-07 | $27.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$10.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-07 | $17.00K derived: sum of 2 quarters · filed 2026-08-07 | $8.00K derived: sum of 3 quarters · filed 2026-08-07 | $73.00K 10-Q · filed 2026-08-07 |
| 2025-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $18.00K derived: sum of 2 quarters · filed 2025-11-06 | $83.00K 10-Q · filed 2025-11-06 | -$8.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $56.00K 10-Q · filed 2025-08-07 | -$35.00K derived: sum of 3 quarters · filed 2026-02-27 | $118.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-03-31 | $65.00K 10-Q · filed 2025-05-08 | -$26.00K derived: sum of 2 quarters · filed 2026-02-27 | $127.00K derived: sum of 3 quarters · filed 2026-02-27 | $34.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-12-31 | -$91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $62.00K derived: sum of 2 quarters · filed 2026-02-27 | -$31.00K derived: sum of 3 quarters · filed 2026-02-27 | $100.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | $153.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $60.00K derived: sum of 2 quarters · filed 2024-11-05 | $191.00K 10-Q · filed 2024-11-05 | $356.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-06-30 | -$93.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $38.00K 10-Q · filed 2024-08-06 | $203.00K derived: sum of 3 quarters · filed 2025-02-27 | $192.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-03-31 | $131.00K 10-Q · filed 2024-05-07 | $296.00K derived: sum of 2 quarters · filed 2025-02-27 | $285.00K derived: sum of 3 quarters · filed 2025-02-27 | $241.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-12-31 | $165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $154.00K derived: sum of 2 quarters · filed 2025-02-27 | $110.00K derived: sum of 3 quarters · filed 2025-02-27 | $196.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$55.00K derived: sum of 2 quarters · filed 2023-11-09 | $31.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $42.00K 10-Q · filed 2023-08-09 | ||
| 2023-03-31 | $86.00K 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | $79.00K 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |